Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Westport Announces Lock-Up Agreements in Support of the... May 1, 2025 Tech 5: Major Players Release Latest Results, Google’s... April 27, 2025 US Capital Gains Tax Guide for Gold and... April 18, 2025 Providence Update on Tuolumne Property Lease April 22, 2025 NorthStar Gaming to Host Q4 and Year-End 2024... April 17, 2025 Silver47 Announces Graduation to Tier 1 Status on... May 23, 2025 US Policy Momentum, Clinical Progress Fueling Psychedelics Market... May 9, 2025 Opawica Explorations Inc. Drills 28m of Mineralization with... April 25, 2025 New Cannabis Consumption Trends, Regulatory Shifts Seen Driving... May 5, 2025 Results of Channel Sampling Program at Halleck Creek May 8, 2025
